NR1H4 and metabolic dysfunction-associated steatotic liver disease: Overall, FXR activation has effective therapeutic effect on NAFLD and cholesterol metabolism, which may become a breakthrough for FXR agonists to be used in the treatment of cardiometabolic diseases.